Researchers in Uganda have made significant strides in vaccine development using a novel adenovector backbone that was previously developed during the COVID-19 pandemic, using funds from the government of Uganda. The developed backbone is an open system that can be used in the development of other vaccines for infectious diseases. Notably, the platform is adaptable for both animal and human testing and is currently being utilized by a consortium of researchers led by the Uganda Virus Research Institute and the MRC/UVRI and LSHTM Uganda Research Unit.
We particularly encourage the participation of journalists, scientists from any discipline (life, physical and social sciences), and storytellers interested in science communication.
Please see the outline of the workshop below.
Dates: November 5, 2024
Aims of the workshop include:
· To develop participants' storytelling skills with a specific focus on writing narratives suitable for publication to wider audiences
CALL FOR ABSTRACTS: IPHASA—International Paediatric HIV/AIDS Symposium for Africa 2024
Theme Equity, Integration, and Innovation: For a sustainable HIV response to end AIDS in children by 2030
Date: 3rd – 5th December 2024
Where: Mestil Hotel, Kampala Uganda
Abstract submission deadline: 24 September 2024
KEMRI-Wellcome Trust Research Programme (KWTRP) is offering sponsored opportunities for talented masters' students to undertake their research projects at the Programmes’ facilities in Nairobi or Kilifi, Kenya. The placement will provide opportunities for recipients to carry out their projects within a high-quality research environment and under the supervision and mentorship of internationally renowned KWTRP scientists. Interested applicants must be registered at a local university in Kenya and will be offered (if successful) a stipend for up to 12 months.
The National Institute for Medical Research (NIMR) in collaboration with the Kenya Medical Research Institute (KEMRI) organized a course on COVID-19 and infectious disease surveillance from July 29th to August 2nd, 2024.